The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.

Advanced glycation end products (AGEs) form non-enzymatically from reactions of proteins with reducing sugars. In the skin, AGEs were reported to accumulate in dermal elastin and collagens and to interact nonspecifically with the cell membrane of dermal fibroblasts. Therefore, AGEs may influence the process of skin aging. We investigated the presence of the AGE receptor RAGE in skin and the influence of AGEs on receptor expression and the formation of extracellular matrix (ECM). Sections of sun-protected and sun-exposed skin were analyzed with monoclonal antibodies against (RAGE), heat-shock protein 47, factor XIIIa, CD31, and CD45. RAGE was mainly expressed in fibroblasts, dendrocytes, and keratinocytes and to a minor extent in endothelial and mononuclear cells. Human foreskin fibroblasts (HFFs) highly expressed RAGE on the protein and mRNA level when analyzed by quantitative Western blotting and real-time PCR. Incubation of HFFs with the specific RAGE ligand Nepsilon-(carboxymethyl)lysine-modified BSA (CML-BSA) and tumor necrosis factor-alpha resulted in significant upregulation of RAGE expression. CML-BSA induced a mildly profibrogenic pattern, increasing connective tissue growth factor, transforming growth factor-beta (TGF-beta) 1, and procollagen-alpha1(I) mRNA, whereas expression of matrix metalloproteinase (MMP)-1, -2, -3, and -12 was unaffected. We conclude that in HFFs, AGE-RAGE interactions may influence the process of skin aging through mild stimulation of ECM gene expression.

[1]  Y. Zou,et al.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.

[2]  Hiroshi Yamamoto,et al.  The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[3]  T. Kislinger,et al.  N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.

[4]  R. Kohn,et al.  Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. , 1981, The Journal of clinical investigation.

[5]  M. Kallioinen,et al.  UV irradiation induces the expression of gelatinases in human skin in vivo. , 1994, Acta dermato-venereologica.

[6]  T. Lyons,et al.  Accumulation of Maillard reaction products in skin collagen in diabetes and aging. , 1993, The Journal of clinical investigation.

[7]  A. McElduff,et al.  Diabetes Control and Complications Trial , 1993 .

[8]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Elmets,et al.  Regulation of TNFα production and release in human and mouse keratinocytes and mouse skin after UV‐B irradiation , 2000, Photodermatology, photoimmunology & photomedicine.

[10]  P. Cruz,et al.  FRAP DNA-dependent protein kinase mediates a late signal transduced from ultraviolet-induced DNA damage. , 2000, The Journal of investigative dermatology.

[11]  C. Jeanmaire,et al.  Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study , 2001, The British journal of dermatology.

[12]  R. Burgeson.  Genetic heterogeneity of collagens. , 1982, The Journal of investigative dermatology.

[13]  R. O. Stuart,et al.  Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. , 1998, Kidney international.

[14]  Gary R. Grotendorst.  Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .

[15]  K. Ikeda,et al.  Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. , 1997, The Journal of investigative dermatology.

[16]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[17]  V. Duance,et al.  Type I and III collagen content and fibre distribution in normal human skin during ageing , 1987, The British journal of dermatology.

[18]  P. Giacomoni,et al.  Factors of skin ageing share common mechanisms , 2004, Biogerontology.

[19]  S. Genuth,et al.  Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro , 1999, Diabetes.

[20]  H. V. Van Wart,et al.  Hydrolysis of a Broad Spectrum of Extracellular Matrix Proteins by Human Macrophage Elastase* , 1997, The Journal of Biological Chemistry.

[21]  H. Freeze,et al.  N‐Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth , 2002, Journal of neurochemistry.

[22]  G. Wondrak,et al.  Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins. , 2002, The Journal of investigative dermatology.

[23]  H. Sakurai,et al.  Dysfunction of dermal fibroblasts induced by advanced glycation end-products (AGEs) and the contribution of a nonspecific interaction with cell membrane and AGEs. , 2002, Journal of dermatological science.

[24]  Kligman Am,et al.  The nature of photoaging: its prevention and repair. , 1986 .

[25]  A. Schmidt,et al.  Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Wautier,et al.  The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats. , 1999, The Journal of pharmacology and experimental therapeutics.

[27]  A. Joly,et al.  Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus. , 2001, Endocrinology.

[28]  Y. Luo,et al.  Ultrastructural characterization of microvasculature in photoaging. , 2001, Journal of dermatological science.

[29]  T. Hughes,et al.  Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products , 2004, Diabetologia.

[30]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[31]  W. Hung,et al.  Role of receptor for advanced glycation end‐product (RAGE) and the JAK/STAT‐signaling pathway in AGE‐induced collagen production in NRK‐49F cells , 2001, Journal of cellular biochemistry.

[32]  A. Gressner,et al.  Up‐regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts , 2001, Hepatology.

[33]  L.,et al.  Glucosylation of human collagen in aging and diabetes mellitus. , 1980, The Journal of clinical investigation.

[34]  R. Fields.  [38] The rapid determination of amino groups with TNBS. , 1972, Methods in enzymology.

[35]  J. Dötsch,et al.  Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[36]  K. Scharffetter-Kochanek,et al.  Ultraviolet B Wavelength Dependence for the Regulation of Two Major Matrix‐Metalloproteinases and Their Inhibitor TIMP‐1 in Human Dermal Fibroblasts , 1996, Photochemistry and photobiology.

[37]  Robert Gniadecki,et al.  Skin aging and natural photoprotection. , 2004, Micron.

[38]  J. Wiegant,et al.  Improved localization of fluorescent tyramides for fluorescence in situ hybridization using dextran sulfate and polyvinyl alcohol. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  S. Horiuchi,et al.  Carboxymethyllysine in Dermal Tissues of Diabetic and Nondiabetic Patients with Chronic Renal Failure: Relevance to Glycoxidation Damage , 2001, Nephron.

[40]  S. Chandler,et al.  Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. , 1996, Biochemical and biophysical research communications.

[41]  J. Wautier,et al.  Advanced glycation end products, their receptors and diabetic angiopathy. , 2001, Diabetes & metabolism.

[42]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[43]  K. Scharffetter-Kochanek,et al.  Activation of protein kinase CK2 is an early step in the ultraviolet B-mediated increase in interstitial collagenase (matrix metalloproteinase-1; MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts. , 2002, The Biochemical journal.

[44]  T. Ley,et al.  Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.